Published in Tissue Eng Part A on January 23, 2015
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell (1993) 33.20
Developmental regulation of the growth plate. Nature (2003) 11.53
p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer (2009) 9.21
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature (2001) 7.06
Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell (1982) 6.61
Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol (2003) 6.21
Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science (2009) 5.68
Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage (2002) 5.64
Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell (2009) 5.43
Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A (2008) 4.48
Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum (2012) 4.28
Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum (2006) 4.16
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet (1993) 3.85
Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature (1977) 3.46
A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat Mater (2007) 3.06
Primary culture and phenotyping of murine chondrocytes. Nat Protoc (2008) 2.78
Articular cartilage defects in 1,000 knee arthroscopies. Arthroscopy (2002) 2.78
Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A (2000) 2.43
Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proc Natl Acad Sci U S A (2010) 2.41
Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell (1978) 2.39
The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit. Cell (2013) 2.37
Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res (2001) 2.37
Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med (2002) 2.36
Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood (2010) 2.22
Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res (2005) 2.20
A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest (2010) 2.06
Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature (1997) 2.03
Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Reports (2014) 2.03
Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc (2010) 2.02
Analysis of cell cycle by flow cytometry. Methods Mol Biol (2004) 1.98
Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum (2003) 1.90
Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem (2001) 1.86
Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol (2007) 1.79
Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am (2014) 1.78
Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells (2007) 1.64
Association of cartilage defects with loss of knee cartilage in healthy, middle-age adults: a prospective study. Arthritis Rheum (2005) 1.49
Tissue engineering for articular cartilage repair--the state of the art. Eur Cell Mater (2013) 1.48
The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines. Stem Cells (2012) 1.46
Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix. Tissue Eng Part A (2010) 1.45
Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose-derived adult stem cells. J Cell Physiol (2006) 1.42
Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol (2009) 1.42
Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A (2010) 1.38
Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.31
FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2. Biochem Biophys Res Commun (2007) 1.28
Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Exp Cell Res (1999) 1.28
Knockdown of p21(Cip1/Waf1) enhances proliferation, the expression of stemness markers, and osteogenic potential in human mesenchymal stem cells. Aging Cell (2011) 1.17
Regulation of the chondrogenic phenotype in culture. Birth Defects Res C Embryo Today (2009) 1.13
Critical requirement for cell cycle inhibitors in sustaining nonproliferative states. J Cell Biol (2007) 1.11
Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix. Eur Cell Mater (2012) 1.11
Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell (2014) 1.10
Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. Neoplasia (2009) 1.09
Autologous chondrocyte implantation. J Bone Joint Surg Am (2006) 1.00
Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells. Arthritis Rheum (2011) 0.96
Effects of growth factors on temporomandibular joint disc cells. Arch Oral Biol (2004) 0.95
Proliferation as a requirement for in vitro chondrogenesis of human mesenchymal stem cells. Stem Cells Dev (2012) 0.94
Col2-GFP reporter marks chondrocyte lineage and chondrogenesis during mouse skeletal development. Dev Dyn (2000) 0.93
Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-grade cell source. Stem Cells Transl Med (2014) 0.92
Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage. Proc Natl Acad Sci U S A (2014) 0.89
Autologous chondrocyte implantation: an overview of technique and outcomes. ANZ J Surg (2010) 0.88
Interleukin-1β promotes proliferation and inhibits differentiation of chondrocytes through a mechanism involving down-regulation of FGFR-3 and p21. Endocrinology (2012) 0.87
Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells. Sci Rep (2013) 0.82
p21Cip-1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro. J Biol Chem (2001) 0.82
Generating cartilage repair from pluripotent stem cells. Tissue Eng Part B Rev (2013) 0.81
FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21(Waf1) and p27(Kip1). Stem Cells (2013) 0.81
A Site-Specific Integrated Col2.3GFP Reporter Identifies Osteoblasts Within Mineralized Tissue Formed In Vivo by Human Embryonic Stem Cells. Stem Cells Transl Med (2014) 0.79
Chondrocyte p21(WAF1/CIP1) expression is increased by dexamethasone but does not contribute to dexamethasone-induced growth retardation in vivo. Calcif Tissue Int (2009) 0.79
In vivo cartilage formation from growth factor modulated articular chondrocytes. Clin Orthop Relat Res (1998) 0.78
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol (2013) 11.58
RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods (2013) 4.85
Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods (2013) 3.26
A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat Mater (2007) 3.06
Nanopattern-induced changes in morphology and motility of smooth muscle cells. Biomaterials (2005) 2.94
Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J Orthop Res (2011) 2.63
Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials (2004) 2.46
Synthetic nanostructures inducing differentiation of human mesenchymal stem cells into neuronal lineage. Exp Cell Res (2007) 2.46
Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun (2002) 2.44
Determination of the Poisson's ratio of the cell: recovery properties of chondrocytes after release from complete micropipette aspiration. J Biomech (2005) 2.29
Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis. Arthritis Rheum (2009) 2.24
Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat Res (2003) 2.10
The role of mechanical loading in the onset and progression of osteoarthritis. Exerc Sport Sci Rev (2005) 2.09
Multifunctional nanorods for gene delivery. Nat Mater (2003) 2.09
Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc (2010) 2.02
Functional characterization of TRPV4 as an osmotically sensitive ion channel in porcine articular chondrocytes. Arthritis Rheum (2009) 2.02
Nanotopography-induced changes in focal adhesions, cytoskeletal organization, and mechanical properties of human mesenchymal stem cells. Biomaterials (2009) 1.97
Advances in targeted genome editing. Curr Opin Chem Biol (2012) 1.97
Synthesis of programmable integrases. Proc Natl Acad Sci U S A (2009) 1.94
Development of universal antidotes to control aptamer activity. Nat Med (2009) 1.93
Viscoelastic properties of human mesenchymally-derived stem cells and primary osteoblasts, chondrocytes, and adipocytes. J Biomech (2007) 1.90
Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules (2005) 1.86
Site-specific molecular diffusion in articular cartilage measured using fluorescence recovery after photobleaching. Ann Biomed Eng (2003) 1.85
Joint degeneration following closed intraarticular fracture in the mouse knee: a model of posttraumatic arthritis. J Orthop Res (2007) 1.85
Biomechanics: cell research and applications for the next decade. Ann Biomed Eng (2009) 1.81
The role of the cytoskeleton in the viscoelastic properties of human articular chondrocytes. J Orthop Res (2004) 1.77
Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum dot-FRET. Mol Ther (2008) 1.76
Chondroprotective role of the osmotically sensitive ion channel transient receptor potential vanilloid 4: age- and sex-dependent progression of osteoarthritis in Trpv4-deficient mice. Arthritis Rheum (2010) 1.75
Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am J Physiol Heart Circ Physiol (2005) 1.73
The effect of the alignment of electrospun fibrous scaffolds on Schwann cell maturation. Biomaterials (2007) 1.72
A thin-layer model for viscoelastic, stress-relaxation testing of cells using atomic force microscopy: do cell properties reflect metastatic potential? Biophys J (2006) 1.69
Light-inducible spatiotemporal control of gene activation by customizable zinc finger transcription factors. J Am Chem Soc (2012) 1.69
Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev (2006) 1.66
Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. ACS Nano (2011) 1.65
Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET. J Control Release (2006) 1.64
Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients. Mol Ther (2013) 1.63
Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J Mol Cell Cardiol (2013) 1.61
Polyethylenimine-grafted multiwalled carbon nanotubes for secure noncovalent immobilization and efficient delivery of DNA. Angew Chem Int Ed Engl (2005) 1.61
Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther (2010) 1.59
The biomechanical role of the chondrocyte pericellular matrix in articular cartilage. Acta Biomater (2005) 1.57
Differentiation potential of adipose derived adult stem (ADAS) cells. Curr Top Dev Biol (2003) 1.57
Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum (2006) 1.56
Zonal changes in the three-dimensional morphology of the chondron under compression: the relationship among cellular, pericellular, and extracellular deformation in articular cartilage. J Biomech (2007) 1.55
Effects of transforming growth factor beta1 and dexamethasone on the growth and chondrogenic differentiation of adipose-derived stromal cells. Tissue Eng (2003) 1.54
Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One (2013) 1.52
Alterations in the mechanical properties of the human chondrocyte pericellular matrix with osteoarthritis. J Biomech Eng (2003) 1.52
The development of posttraumatic arthritis after articular fracture. J Orthop Trauma (2006) 1.51
How vinculin regulates force transmission. Proc Natl Acad Sci U S A (2013) 1.51
Molecular diffusion in tissue-engineered cartilage constructs: effects of scaffold material, time, and culture conditions. J Biomed Mater Res B Appl Biomater (2004) 1.51
Concise review: Adipose-derived stromal vascular fraction cells and stem cells: let's not get lost in translation. Stem Cells (2011) 1.50
Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res Ther (2010) 1.48
Tissue engineering for articular cartilage repair--the state of the art. Eur Cell Mater (2013) 1.48
Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials (2006) 1.48
Interleukin-1, tumor necrosis factor-alpha, and transforming growth factor-beta 1 and integrative meniscal repair: influences on meniscal cell proliferation and migration. Arthritis Res Ther (2011) 1.47
Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix. Tissue Eng Part A (2010) 1.45
Chondrogenic differentiation of adipose-derived adult stem cells by a porous scaffold derived from native articular cartilage extracellular matrix. Tissue Eng Part A (2009) 1.44
Aligned Protein-Polymer Composite Fibers Enhance Nerve Regeneration: A Potential Tissue-Engineering Platform. Adv Funct Mater (2007) 1.43
Significance of synthetic nanostructures in dictating cellular response. Nanomedicine (2005) 1.42
Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med (2009) 1.42
Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials (2005) 1.42
Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose-derived adult stem cells. J Cell Physiol (2006) 1.42
Urea as a passive transport marker for arthritis biomarker studies. Arthritis Rheum (2002) 1.41
Osteoarthritic changes in the biphasic mechanical properties of the chondrocyte pericellular matrix in articular cartilage. J Biomech (2005) 1.41
Surface-aminated electrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells. Biomaterials (2006) 1.41
Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng (2006) 1.41
Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine (2006) 1.38
The mechanical properties of the human hip capsule ligaments. J Arthroplasty (2002) 1.38
Influence of oxygen on the proliferation and metabolism of adipose derived adult stem cells. J Cell Physiol (2005) 1.37
Developmental and osteoarthritic changes in Col6a1-knockout mice: biomechanics of type VI collagen in the cartilage pericellular matrix. Arthritis Rheum (2009) 1.36
Loss of cartilage structure, stiffness, and frictional properties in mice lacking PRG4. Arthritis Rheum (2010) 1.36
Absence of posttraumatic arthritis following intraarticular fracture in the MRL/MpJ mouse. Arthritis Rheum (2008) 1.35
Mechanical signals as regulators of stem cell fate. Curr Top Dev Biol (2004) 1.35
Characterization of topographical effects on macrophage behavior in a foreign body response model. Biomaterials (2010) 1.33
Human adipose-derived cells: an update on the transition to clinical translation. Regen Med (2012) 1.33
TRPV4-mediated mechanotransduction regulates the metabolic response of chondrocytes to dynamic loading. Proc Natl Acad Sci U S A (2014) 1.32
Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.31
Spatial mapping of the biomechanical properties of the pericellular matrix of articular cartilage measured in situ via atomic force microscopy. Biophys J (2010) 1.31
Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Free Radic Biol Med (2011) 1.31
Structure-guided reprogramming of serine recombinase DNA sequence specificity. Proc Natl Acad Sci U S A (2010) 1.31
Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia. J Am Soc Nephrol (2005) 1.30
Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials (2011) 1.30
SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways. Antioxid Redox Signal (2013) 1.29
Induction of osteoarthritis and metabolic inflammation by a very high-fat diet in mice: effects of short-term exercise. Arthritis Rheum (2012) 1.29
In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials (2007) 1.28
Self-assembled supramolecular hydrogels formed by biodegradable PEO-PHB-PEO triblock copolymers and alpha-cyclodextrin for controlled drug delivery. Biomaterials (2006) 1.26
Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases. Nucleic Acids Res (2011) 1.25
Genetic and cellular evidence of decreased inflammation associated with reduced incidence of posttraumatic arthritis in MRL/MpJ mice. Arthritis Rheum (2013) 1.25
The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials (2004) 1.25
Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries. Biomaterials (2004) 1.25